MEAGHAN STUTESMAN: Open Payments
NPI 1316312275 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 14 payments from 7 companies in 2025. Trend: 2023 $409 · 2024 $348 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| BridgeBio Pharma, Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| Edwards Lifesciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $17 |
Products named: Ozempic, ELIQUIS, Attruby, LifeVest, ENTRESTO, SAPIEN 3 Ultra RESILIA, Wegovy.
Industry payments across IN — which companies pay providers there.
